News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,833 Results
Type
Article (42457)
Company Profile (263)
Press Release (676112)
Multimedia
Podcasts (62)
Webinars (15)
Section
Business (208163)
Career Advice (2059)
Deals (35858)
Drug Delivery (99)
Drug Development (82621)
Employer Resources (175)
FDA (16571)
Job Trends (15154)
News (351742)
Policy (33285)
Tag
Academia (2668)
Accelerated approval (11)
Adcomms (23)
Allergies (97)
Alliances (51108)
ALS (112)
Alzheimer's disease (1493)
Antibody-drug conjugate (ADC) (161)
Approvals (16562)
Artificial intelligence (332)
Autoimmune disease (30)
Automation (19)
Bankruptcy (364)
Best Places to Work (11791)
BIOSECURE Act (20)
Biosimilars (126)
Biotechnology (181)
Bladder cancer (94)
Brain cancer (35)
Breast cancer (370)
Cancer (2949)
Cardiovascular disease (227)
Career advice (1729)
Career pathing (32)
CAR-T (192)
CDC (31)
Cell therapy (521)
Cervical cancer (22)
Clinical research (67953)
Collaboration (1066)
Company closure (3)
Compensation (690)
Complete response letters (25)
COVID-19 (2704)
CRISPR (64)
C-suite (341)
Cystic fibrosis (116)
Data (3048)
Decentralized trials (2)
Denatured (20)
Depression (67)
Diabetes (353)
Diagnostics (6556)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (145)
Drug pricing (122)
Drug shortages (28)
Duchenne muscular dystrophy (132)
Earnings (87987)
Editorial (42)
Employer branding (22)
Employer resources (151)
Events (115734)
Executive appointments (864)
FDA (18275)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (967)
Gene editing (138)
Generative AI (28)
Gene therapy (396)
GLP-1 (815)
Government (4606)
Grass and pollen (5)
Guidances (182)
Healthcare (19161)
HIV (41)
Huntington's disease (30)
IgA nephropathy (40)
Immunology and inflammation (162)
Immuno-oncology (11)
Indications (40)
Infectious disease (2883)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (121)
Interviews (317)
IPO (16687)
IRA (44)
Job creations (3762)
Job search strategy (1466)
Kidney cancer (14)
Labor market (53)
Layoffs (511)
Leadership (21)
Legal (8088)
Liver cancer (81)
Longevity (12)
Lung cancer (409)
Lymphoma (211)
Machine learning (11)
Management (58)
Manufacturing (398)
MASH (94)
Medical device (13690)
Medtech (13695)
Mergers & acquisitions (19901)
Metabolic disorders (876)
Multiple sclerosis (100)
NASH (18)
Neurodegenerative disease (127)
Neuropsychiatric disorders (36)
Neuroscience (2198)
NextGen: Class of 2025 (6631)
Non-profit (4629)
Now hiring (47)
Obesity (442)
Opinion (223)
Ovarian cancer (102)
Pain (114)
Pancreatic cancer (125)
Parkinson's disease (191)
Partnered (22)
Patents (304)
Patient recruitment (172)
Peanut (50)
People (59150)
Pharmaceutical (67)
Pharmacy benefit managers (21)
Phase I (21236)
Phase II (29904)
Phase III (22246)
Pipeline (1675)
Policy (206)
Postmarket research (2606)
Preclinical (9086)
Press Release (67)
Prostate cancer (143)
Psychedelics (41)
Radiopharmaceuticals (257)
Rare diseases (482)
Real estate (6071)
Recruiting (68)
Regulatory (23137)
Reports (50)
Research institute (2436)
Resumes & cover letters (355)
Rett syndrome (10)
RNA editing (9)
RSV (50)
Schizophrenia (87)
Series A (164)
Series B (112)
Service/supplier (11)
Sickle cell disease (61)
Special edition (18)
Spinal muscular atrophy (156)
Sponsored (33)
Startups (3711)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (57)
The Weekly (40)
Vaccines (799)
Venture capital (55)
Weight loss (272)
Women's health (47)
Worklife (16)
Date
Today (78)
Last 7 days (356)
Last 30 days (1905)
Last 365 days (31773)
2025 (17218)
2024 (35860)
2023 (40728)
2022 (51874)
2021 (56457)
2020 (54785)
2019 (47406)
2018 (35752)
2017 (32898)
2016 (32349)
2015 (38362)
2014 (32062)
2013 (27112)
2012 (29191)
2011 (29878)
2010 (27952)
Location
Africa (749)
Alabama (64)
Alaska (7)
Arizona (244)
Arkansas (13)
Asia (39319)
Australia (6472)
California (7515)
Canada (2387)
China (691)
Colorado (322)
Connecticut (327)
Delaware (192)
Europe (86053)
Florida (1124)
Georgia (251)
Hawaii (1)
Idaho (59)
Illinois (651)
India (27)
Indiana (365)
Iowa (18)
Japan (231)
Kansas (110)
Kentucky (29)
Louisiana (14)
Maine (73)
Maryland (1041)
Massachusetts (5643)
Michigan (247)
Minnesota (464)
Mississippi (3)
Missouri (92)
Montana (30)
Nebraska (25)
Nevada (81)
New Hampshire (69)
New Jersey (2090)
New Mexico (30)
New York (2113)
North Carolina (1121)
North Dakota (10)
Northern California (3306)
Ohio (239)
Oklahoma (17)
Oregon (38)
Pennsylvania (1627)
Puerto Rico (18)
Rhode Island (37)
South America (1135)
South Carolina (36)
South Dakota (1)
Southern California (2812)
Tennessee (128)
Texas (1135)
United States (27983)
Utah (224)
Virginia (190)
Washington D.C. (72)
Washington State (639)
West Virginia (4)
Wisconsin (70)
718,833 Results for "milestone scientific inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
May 19, 2025
·
5 min read
Press Releases
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
May 15, 2025
·
7 min read
Press Releases
Ancora Heart Inc. Reaches First Enrollment Milestone in CORCINCH-HF Heart Failure Pivotal Trial
June 23, 2025
·
5 min read
Press Releases
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
April 15, 2025
·
8 min read
Press Releases
Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board
June 18, 2025
·
2 min read
Policy
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announces that it has received regulatory approval from Brazil’s National Health Surveillance Agency (ANVISA) to market and sell its CompuFlo® Epidural System in Brazil.
June 18, 2024
·
4 min read
Press Releases
Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment
July 17, 2025
·
2 min read
Press Releases
Milestone Pharmaceuticals Announces Proposed Public Offering
July 11, 2025
·
5 min read
Business
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
Milestone Scientific Inc. today provides a business update and announces financial results for the first quarter ended March 31, 2024.
May 16, 2024
·
9 min read
Business
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provides a business update and announces financial results for the year ending December 31, 2023.
April 1, 2024
·
10 min read
1 of 71,884
Next
